US4152170A
(en)
*
|
1975-06-18 |
1979-05-01 |
Sumitomo Chemical Company, Ltd. |
Cross-linked pullulan
|
US4344930A
(en)
*
|
1975-10-30 |
1982-08-17 |
Colgate-Palmolive Company |
Skin care sponge
|
US4470975A
(en)
*
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
SE445013B
(sv)
*
|
1979-06-21 |
1986-05-26 |
Landstingens Inkopscentral |
Medel for att forebygga eller behandla infektioner hos menniskor och djur
|
US4292972A
(en)
*
|
1980-07-09 |
1981-10-06 |
E. R. Squibb & Sons, Inc. |
Lyophilized hydrocolloio foam
|
EP0086627B1
(en)
*
|
1982-02-12 |
1985-08-28 |
Unitika Ltd. |
Anti-cancer device
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US4783448A
(en)
*
|
1983-06-07 |
1988-11-08 |
Perstorp Ab |
Method for cleansing an infected sore
|
US4769022A
(en)
*
|
1986-05-02 |
1988-09-06 |
Minnesota Mining And Manufacturing Company |
Cleansing pad
|
SE452469B
(sv)
*
|
1986-06-18 |
1987-11-30 |
Pharmacia Ab |
Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
|
US4851232A
(en)
*
|
1987-02-13 |
1989-07-25 |
Alza Corporation |
Drug delivery system with means for obtaining desirable in vivo release rate pattern
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
CA2017570C
(en)
*
|
1989-05-31 |
2000-12-19 |
James R. Gross |
Porous structure of an absorbent polymer
|
US5354290A
(en)
*
|
1989-05-31 |
1994-10-11 |
Kimberly-Clark Corporation |
Porous structure of an absorbent polymer
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5241009A
(en)
*
|
1990-05-07 |
1993-08-31 |
Kimberly-Clark Corporation |
Polymeric composition containing carboxy nueutralized with lithium or potassium
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
AU2572692A
(en)
|
1991-09-09 |
1993-04-05 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods and devices for treating hemophilia and aids
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
DK0625070T3
(da)
*
|
1991-12-20 |
1999-02-22 |
Allied Signal Inc |
Materialer med lav massefylde, som har høje overfladearealer, og genstande dannet derudfra til anvendelse ved genvindingen
|
US5502082A
(en)
*
|
1991-12-20 |
1996-03-26 |
Alliedsignal Inc. |
Low density materials having good compression strength and articles formed therefrom
|
US5525710A
(en)
*
|
1991-12-20 |
1996-06-11 |
Alliedsignal Inc. |
Highly porous chitosan bodies
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
DE4209160A1
(de)
*
|
1992-03-20 |
1993-09-30 |
Bauer Kurt Heinz Prof Dr |
Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5409703A
(en)
*
|
1993-06-24 |
1995-04-25 |
Carrington Laboratories, Inc. |
Dried hydrogel from hydrophilic-hygroscopic polymer
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
DE4442606C2
(de)
*
|
1994-11-30 |
1998-09-17 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
DE4442605A1
(de)
*
|
1994-11-30 |
1996-06-05 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
DE19729273C2
(de)
*
|
1997-07-09 |
2000-08-17 |
Aventis Res & Tech Gmbh & Co |
Thermoplastische Mischung auf 1,4-alpha-D-Polyglucanbasis, Verfahren zu deren Herstellung und Verwendung
|
DE59804823D1
(de)
|
1997-09-25 |
2002-08-22 |
Bayer Ag |
Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
|
US6261679B1
(en)
*
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
US7790192B2
(en)
|
1998-08-14 |
2010-09-07 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US6152943A
(en)
*
|
1998-08-14 |
2000-11-28 |
Incept Llc |
Methods and apparatus for intraluminal deposition of hydrogels
|
US6605294B2
(en)
|
1998-08-14 |
2003-08-12 |
Incept Llc |
Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6703047B2
(en)
*
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
JP4159254B2
(ja)
*
|
1998-08-14 |
2008-10-01 |
インセプト エルエルシー |
ヒドロゲルのインサイチュ形成のための方法および装置
|
EP1147148B1
(en)
*
|
1998-08-31 |
2005-06-08 |
Cornell Research Foundation, Inc. |
Dextran-maleic acid monoesters and hydrogels based thereon
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
RU2246295C2
(ru)
*
|
1998-11-02 |
2005-02-20 |
Элзэ Копэрейшн |
Лекарственная форма c постоянной скоростью высвобождения лекарственного вещества, ядро лекарственной формы и способ обеспечения облегченного высвобождения лекарственного вещества из лекарственной формы
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
WO2000060956A1
(en)
|
1999-04-12 |
2000-10-19 |
Cornell Research Foundation, Inc. |
Hydrogel-forming system with hydrophobic and hydrophilic components
|
US6716445B2
(en)
*
|
1999-04-12 |
2004-04-06 |
Cornell Research Foundation, Inc. |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
|
US6541678B2
(en)
*
|
1999-09-27 |
2003-04-01 |
Brennen Medical, Inc. |
Immunostimulating coating for surgical devices
|
JP2003516345A
(ja)
*
|
1999-12-09 |
2003-05-13 |
アルザ・コーポレーション |
抗ウイルス剤
|
CA2431205C
(en)
|
2000-12-05 |
2005-08-23 |
Alexander Macgregor |
Hydrostatic delivery system for controlled delivery of agent
|
US20040219186A1
(en)
*
|
2001-08-16 |
2004-11-04 |
Ayres James W. |
Expandable gastric retention device
|
EP1492509A1
(en)
*
|
2001-12-18 |
2005-01-05 |
ALZA Corporation |
Dosage form providing time-varying patterns of drug delivery
|
KR20040066177A
(ko)
*
|
2001-12-19 |
2004-07-23 |
알자 코포레이션 |
친수성 거대분자의 경구 생체이용률을 증가시키기 위한제형 및 투여 형태
|
WO2003053400A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
CA2483655A1
(en)
*
|
2002-04-29 |
2003-11-13 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
RU2004134728A
(ru)
*
|
2002-05-31 |
2005-06-10 |
Алза Корпорейшн (Us) |
Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
|
US7776314B2
(en)
*
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US20050175697A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Novel drug compositions and dosage forms of topiramate
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
EP1534238A1
(en)
*
|
2002-07-29 |
2005-06-01 |
ALZA Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
GB2395126A
(en)
*
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
WO2004048451A2
(en)
|
2002-11-26 |
2004-06-10 |
Genencor International, Inc. |
Optical information carrier comprising immobilized proteorhodopsin
|
US20040122349A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Lafontaine Daniel M. |
Closure device with textured surface
|
US8709038B2
(en)
*
|
2002-12-20 |
2014-04-29 |
Boston Scientific Scimed, Inc. |
Puncture hole sealing device
|
US20040166160A1
(en)
*
|
2003-01-14 |
2004-08-26 |
Ramkumar Subramanian |
Methods and dosage forms with modified viscosity layers
|
DE10318802A1
(de)
*
|
2003-04-17 |
2004-11-04 |
Aesculap Ag & Co. Kg |
Selbsthaftendes resorbierbares Hämostyptikum
|
US7331979B2
(en)
*
|
2003-06-04 |
2008-02-19 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9289195B2
(en)
|
2003-06-04 |
2016-03-22 |
Access Closure, Inc. |
Auto-retraction apparatus and methods for sealing a vascular puncture
|
CA2673334C
(en)
|
2003-06-16 |
2013-11-12 |
Andrx Pharmaceuticals, Llc |
Oral extended-release composition
|
US7942897B2
(en)
*
|
2003-07-10 |
2011-05-17 |
Boston Scientific Scimed, Inc. |
System for closing an opening in a body cavity
|
AU2004264316A1
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
PL1658054T3
(pl)
*
|
2003-08-06 |
2007-11-30 |
Gruenenthal Gmbh |
Postać aplikacyjna zabezpieczona przed nadużyciem
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8075872B2
(en)
*
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
MXPA06002067A
(es)
*
|
2003-08-22 |
2006-08-11 |
Johnson & Johnson |
Suministro gradual de topiramato durante periodo prolongado.
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
KR20060115860A
(ko)
*
|
2003-09-26 |
2006-11-10 |
알자 코포레이션 |
활성 제제의 서방성 전달을 위한 oros 푸시-스틱
|
WO2005072079A2
(en)
*
|
2003-09-26 |
2005-08-11 |
Alza Coporation |
Drug coating providing high drug loading and methods for providing the same
|
WO2005030181A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
JP2007511519A
(ja)
*
|
2003-11-14 |
2007-05-10 |
アルザ・コーポレーシヨン |
液状投薬形態物におけるトピラメートの制御放出
|
US20050107867A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Taheri Syde A. |
Temporary absorbable venous occlusive stent and superficial vein treatment method
|
JP2007516297A
(ja)
*
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
MXPA06007509A
(es)
*
|
2003-12-29 |
2007-10-18 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas.
|
US20050234336A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Beckman Andrew T |
Apparatus and method for marking tissue
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
EP1761265A2
(en)
*
|
2004-06-28 |
2007-03-14 |
ALZA Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US8080705B2
(en)
*
|
2004-07-28 |
2011-12-20 |
The Procter & Gamble Company |
Superabsorbent polymers comprising direct covalent bonds between polymer chain segments and method of making them
|
EP1791520A2
(en)
*
|
2004-08-19 |
2007-06-06 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
US8348971B2
(en)
|
2004-08-27 |
2013-01-08 |
Accessclosure, Inc. |
Apparatus and methods for facilitating hemostasis within a vascular puncture
|
WO2006026412A2
(en)
*
|
2004-08-31 |
2006-03-09 |
Vnus Medical Technologies, Inc. |
Apparatus and material composition for permanent occlusion of a hollow anatomical structure
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US8262693B2
(en)
*
|
2004-11-05 |
2012-09-11 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US7972354B2
(en)
|
2005-01-25 |
2011-07-05 |
Tyco Healthcare Group Lp |
Method and apparatus for impeding migration of an implanted occlusive structure
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
CA2605180A1
(en)
*
|
2005-04-19 |
2006-10-26 |
Alza Corporation |
Controlled delivery dosage form of tramadol and gabapentin
|
US7806856B2
(en)
*
|
2005-04-22 |
2010-10-05 |
Accessclosure, Inc. |
Apparatus and method for temporary hemostasis
|
EP2502621A1
(en)
|
2005-06-27 |
2012-09-26 |
Valeant International (Barbados) SRL |
Crystalline forms of bupropion HBr
|
JP2009500339A
(ja)
*
|
2005-06-29 |
2009-01-08 |
アルザ・コーポレーシヨン |
浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
|
JP2009507774A
(ja)
*
|
2005-08-04 |
2009-02-26 |
アルザ・コーポレーシヨン |
改良された性質を提供するポリマー混合物による半透過性膜を含んでなる浸透性用量形態物
|
US20070087061A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090041825A1
(en)
|
2006-02-10 |
2009-02-12 |
Kotov Nicholas A |
Cell culture well-plates having inverted colloidal crystal scaffolds
|
US8795709B2
(en)
|
2006-03-29 |
2014-08-05 |
Incept Llc |
Superabsorbent, freeze dried hydrogels for medical applications
|
US9017361B2
(en)
*
|
2006-04-20 |
2015-04-28 |
Covidien Lp |
Occlusive implant and methods for hollow anatomical structure
|
EP2077765A2
(en)
|
2006-09-13 |
2009-07-15 |
Accessclosure, Inc. |
Apparatus for sealing a vascular puncture
|
US8623842B2
(en)
|
2006-09-27 |
2014-01-07 |
Hemostasis, Llc |
Hemostatic agent and method
|
US8414550B2
(en)
*
|
2006-09-29 |
2013-04-09 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20090062233A1
(en)
|
2007-08-09 |
2009-03-05 |
Xin Ji |
Modified starch material of biocompatible hemostasis
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US20090088723A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Accessclosure, Inc. |
Apparatus and methods for treating pseudoaneurysms
|
US7993367B2
(en)
*
|
2007-09-28 |
2011-08-09 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
EP2209426A4
(en)
*
|
2007-11-02 |
2015-04-22 |
Incept Llc |
APPARATUS AND METHODS FOR CLOSING VASCULAR PERFORATION
|
EP2249811A1
(en)
|
2008-01-25 |
2010-11-17 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
CA2716872C
(en)
|
2008-02-29 |
2015-02-10 |
Ferrosan Medical Devices A/S |
Device for promotion of hemostasis and/or wound healing
|
US8585646B2
(en)
|
2008-03-03 |
2013-11-19 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
US9061087B2
(en)
*
|
2008-03-04 |
2015-06-23 |
Hemostasis, Llc |
Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
|
US9364206B2
(en)
|
2008-04-04 |
2016-06-14 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US8029533B2
(en)
|
2008-04-04 |
2011-10-04 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
EP2273983B1
(en)
*
|
2008-05-09 |
2016-07-20 |
Grünenthal GmbH |
Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
|
US20100040672A1
(en)
*
|
2008-06-09 |
2010-02-18 |
Northwestern University |
Delivery of therapeutics
|
US10799593B2
(en)
|
2008-06-09 |
2020-10-13 |
Northwestern University |
Nanodiamond particle complexes
|
WO2010056915A1
(en)
*
|
2008-11-12 |
2010-05-20 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
JP5890182B2
(ja)
|
2009-02-12 |
2016-03-22 |
インセプト エルエルシー |
ヒドロゲルプラグによる薬物送達
|
CA2760704C
(en)
*
|
2009-05-04 |
2017-10-03 |
Incept, Llc |
Biomaterials for track and puncture closure
|
CA2952805C
(en)
|
2009-06-05 |
2021-06-01 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematopoietic cells
|
PL2456424T3
(pl)
|
2009-07-22 |
2013-12-31 |
Gruenenthal Gmbh |
Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
|
PL2456427T3
(pl)
|
2009-07-22 |
2015-07-31 |
Gruenenthal Gmbh |
Wytłaczana na gorąco postać dawki o kontrolowanym uwalnianiu
|
US20110052663A1
(en)
*
|
2009-09-01 |
2011-03-03 |
Hemostasis, Llc |
Hemostatic Sponge with Enzyme and Method of Manufacture
|
US8434489B2
(en)
*
|
2009-10-23 |
2013-05-07 |
Conceptus, Inc. |
Contraceptive devices and methods
|
CA3042067C
(en)
|
2009-12-15 |
2022-10-18 |
Incept, Llc |
Implants and biodegradable fiducial markers
|
US9579285B2
(en)
*
|
2010-02-03 |
2017-02-28 |
Gruenenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
WO2011122524A1
(ja)
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
MX2013002293A
(es)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
US9820728B2
(en)
|
2011-01-19 |
2017-11-21 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
WO2012100091A2
(en)
|
2011-01-19 |
2012-07-26 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9386968B2
(en)
|
2011-05-11 |
2016-07-12 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US20130028972A1
(en)
|
2011-07-29 |
2013-01-31 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
PE20141638A1
(es)
|
2011-07-29 |
2014-11-22 |
Gruenenthal Chemie |
Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
|
KR20190090048A
(ko)
|
2011-12-05 |
2019-07-31 |
인셉트, 엘엘씨 |
의료용 유기젤 방법 및 조성물
|
US20130225697A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
RU2657955C2
(ru)
|
2012-03-06 |
2018-06-18 |
Ферросан Медикал Дивайсиз А/С |
Контейнер под давлением, содержащий гемостатическую пасту
|
US8721680B2
(en)
|
2012-03-23 |
2014-05-13 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9757105B2
(en)
|
2012-03-23 |
2017-09-12 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
EA201401139A1
(ru)
|
2012-04-18 |
2015-03-31 |
Грюненталь Гмбх |
Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
BR112014030962A2
(pt)
|
2012-06-12 |
2017-06-27 |
Ferrosan Medical Devices As |
métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
|
JP6445537B2
(ja)
|
2013-05-29 |
2018-12-26 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
RU2700162C2
(ru)
|
2013-06-21 |
2019-09-13 |
Ферросан Медикал Дивайсиз А/С |
Расширенная под вакуумом сухая композиция и шприц для ее сохранения
|
US10765774B2
(en)
|
2013-07-09 |
2020-09-08 |
Ethicon, Inc. |
Hemostatic pad assembly kit and method
|
JP6449871B2
(ja)
|
2013-07-12 |
2019-01-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エチレン−酢酸ビニルポリマーを含有する改変防止剤形
|
JP6480936B2
(ja)
|
2013-11-26 |
2019-03-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
クライオミリングによる粉末状医薬組成物の調製
|
EP3470094B1
(en)
|
2013-12-11 |
2020-07-22 |
Ferrosan Medical Devices A/S |
Dry composition comprising an extrusion enhancer
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
EP3148512A1
(en)
|
2014-05-26 |
2017-04-05 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
CA2960309A1
(en)
|
2014-10-13 |
2016-04-21 |
Ferrosan Medical Devices A/S |
Dry composition for use in haemostasis and wound healing
|
WO2016065245A1
(en)
|
2014-10-24 |
2016-04-28 |
Incept, Llc |
Extra luminal scaffold
|
JP7092502B2
(ja)
|
2014-12-10 |
2022-06-28 |
インセプト・リミテッド・ライアビリティ・カンパニー |
ハイドロゲル薬物送達インプラント
|
CN107206165B
(zh)
|
2014-12-24 |
2020-10-23 |
弗罗桑医疗设备公司 |
用于保持并混合第一和第二物质的注射器
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
EP4279064A3
(en)
|
2015-05-12 |
2024-02-28 |
Incept, LLC |
Drug delivery from hydrogels
|
AU2016290433B2
(en)
|
2015-07-03 |
2018-05-24 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
JP2018526414A
(ja)
|
2015-09-10 |
2018-09-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
|
JP2018536484A
(ja)
|
2015-11-25 |
2018-12-13 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc |
形状変化する薬物送達デバイス及び方法
|
EP3515406A1
(en)
|
2016-09-23 |
2019-07-31 |
Incept, LLC |
Intracameral drug delivery depots
|
KR20200123181A
(ko)
|
2018-02-16 |
2020-10-28 |
에스페리온 테라피유틱스 인코포레이티드 |
뱀페도익산의 지속 방출형 제제
|
WO2019215274A1
(en)
|
2018-05-09 |
2019-11-14 |
Ferrosan Medical Devices A/S |
Method for preparing a haemostatic composition
|
CN110732037B
(zh)
|
2018-07-20 |
2023-05-26 |
广州倍绣生物技术有限公司 |
止血糊剂及其制备方法
|
WO2021029020A1
(ja)
|
2019-08-13 |
2021-02-18 |
大塚製薬株式会社 |
経口医薬組成物
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
CN113304305A
(zh)
*
|
2021-04-27 |
2021-08-27 |
宁波绿糖生物科技有限公司 |
一种葡聚糖微球及其制备方法和应用
|